Vitrolife AB (publ) (LON:0YAY)

Market Cap	990.60M -41.9%
Revenue (ttm)	277.30M -4.7%
Net Income	-404.02M
EPS	-2.98
Shares Out	n/a
PE Ratio	n/a
Forward PE	20.24
Dividend	0.09 (0.09%)
Ex-Dividend Date	Apr 30, 2025

Volume	5,525
Average Volume	36,782
Open	91.10
Previous Close	90.50
Day's Range	90.00 - 93.45
52-Week Range	84.75 - 169.40
Beta	1.97
RSI	46.47
Earnings Date	Mar 26, 2026

About Vitrolife AB

Vitrolife AB (publ) provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas. It offers sperm processing, oocyte retrieval needles, micromanipulation pipettes, time-lapse systems, and evaluation tools, laser and imaging systems, IVF media and oil, embryo transfer, cryopreservation, and genomics kits. The company also provides eWitness and Labware products, such as dishes, pipettes, tubes, and VitroTemp. The company was incorporated in 1989 and is based in Gothenburg, Sweden.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1989
• Employees: 1,151
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0YAY

Financial Performance

Financial numbers in SEK